Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
99 Cards in this Set
- Front
- Back
ARB's mechanism
|
block AT1 receptors competitively but essentially irreversibly
|
|
Differences b/w ACEI's and ARB's (4)
|
1)ARB's reduce angiotensin receptor activation more than ACEI's
2)AT2 receptors not inhibited by ARB 3)ARB's do NOT incr bradykinin []s, so no cough 4)ARB's have much less angioedema |
|
ARB's ADR's (3)
|
1)FETOPATHIC
2)do NOT use w/ renal stenosis 3)hyperkalemia if person has renal disase |
|
ARB's therapeutic uses (2)
|
1)3-6wks to work
2)less effective in blacks and old (low plasma renin) |
|
Direct inhibitor of activity of renin
|
Aliserken
|
|
Antagonists of the aldosterone receptor (2)
|
Sprionolactone
Eplerenone |
|
Endothelin receptor antagonists
|
Ambrisentan
|
|
Diuretics def
|
agents that incr rate of urine formation
|
|
Water as a TRUE PHYSIOLOGIC diuretic
a)mechanism b)general therapeutic uses (2) |
a)incr urine volume and rate of formation by decr osmolarity of blood and decr ADH secretion
b1)incr rate of excretion of toxic drugs b2)dilute drugs which may prcipitate in kidney (like sulfa) |
|
Osmotic Diuretics characteristics (4)
|
1)free glomerular filtration
2)limited tubular reabsorption (so it stays in nephron) 3)inert/nontoxic 4)resistant to metabolic alteration |
|
Osmotic Diuretics mechanism (3)
|
1)loop of Henle is major site of axn
2)incr osmotic activity in renal tubule 3)agent is not reabsorbed and carries w/ it and equivalent amt of fluid |
|
Osmotic Diuretics
a)ADR's |
rapid expansion of ECF may cause cardiac failure
|
|
Osmotic Diuretics therapeutic uses (4)
|
1)renal failure
2)glaucoma 3)edema 4)reduce spinal fluid before neurosurgery |
|
Osmotic Diuretics 2ex and 2 characteristics of each
|
1)Mannitol (most common, poor GI absorption so give IV)
2)Isosorbide (used orally, but poor diuresis) |
|
All carbonic anhydrase inhibitors have...and ex
|
a free sulfonamide group
Acetazolamide |
|
Overall axn of carbonic anhydrase inhibitor (5)
|
1)alkaline urine (via incr HCO3 excretion)
2)diuresis (via incr water excretion) 3)metabolic acidosis (via decr H+ excretion) 4)Na/K excretion incr (via excess Na/K exchange) 5)self-limiting b/c body compensates so not a good diuretic |
|
carbonic anhydrase inhibitor uses (5)
|
1)open glaucoma
2)reduces epileptic seizure 3)alkalanize urine 4)treat altitude sickness 5)not really as a diuretic |
|
carbonic anhydrase inhibitor ADR's (4)
|
1)parasthesia (numbness of extremeties)
2)drowsiness 3)alkaline urine -> precipitates CaPO4 -> kidney stones 4)allergic rxn (crosses w/ sulfa allergy) |
|
Thiazide diuretics mechanism (3)
|
1)inhibits Na-Cl symport in DISTAL SEGMENTS of nephron
2)competes at Cl binding site 3)significant K+ loss due to excess Na remaining in DISTAL tubule |
|
Thiazide diuretics other axns (4)
|
1)chronic use DECREASES URIC ACID EXCRETION (so it builds up)
2)decr Ca excretion 3)incr Mg excretion 4)incr halogen excretion (for radiation poisoning) |
|
Thiazide ADR's (4)
|
1)hyponatremia/dehydration
2)K+ depletion (requires K+ supplement or cotherapy w/ K+ spaing diuretic) 3)hyperglycemia in DM 4)uric acid retention = gout |
|
Thiazide uses (3)
|
1)HTN
2)edema of CHF 3)edema of chronic liver/renal disease |
|
Loop diuretics have what in common (3)
|
1)prompt onset w/ short duration
2)inhibit Na/Cl transport in ascending loop 3)little acid/base change |
|
2 Loop diuretics
|
1)lasix
2)ethacrynic acid |
|
Loop diuretics mechanism (4)
|
1)mainly acts at ASCENDING LOOP OF HENLE inhibiting transport of Na/Cl
2)inhibit Na-K-2Cl symport 3)acts at Cl binding site 4)reduces counter-current multiplier mechanism (less []ed urine) |
|
Loop diuretics other effects (2)
|
1)incr K+/Mg/Ca excretion
2)decr uric acid excretion (so uric acid retention) |
|
Loop diuretics uses (3)
|
1)edema in general
2)refractory edema 3)drug OD (enhances rate of drug elimination) |
|
Loop diuretics ADR's (5)
|
1)dehydration, hyponatremia
2)hypotension 3)hypokalemia/magnesemia (arrhythmias) 4)uric acid retention (gout) 5)ototoxicity (mainly w/ ethacrynic acid) |
|
Type1 K+ sparing diuretics
a)ex b)mechanism (3) |
ex)spironolactone
1)aldosterone receptor antagonist in DISTAL TUBULE AND COLLECTING DUCT 2)this enhances Na/water/K retention 3)diuretic effect limited by hormonal regulation of aldosterone |
|
Type1 K+ sparing diuretics ADR's (3)
|
1)hyperkalemia
2)GI symptoms 3)androgen like effects |
|
Type1 K+ sparing diuretics uses (2)
|
1)edema of HTN (use w/ thiazides)
2)combine w/ thiazides to prevent K+ loss |
|
Type2 K+ sparing diuretics
a)ex(2) b)mechanism (2) |
ex)Amiloride, Triamterene
1)inhibit LIMITED Na channels in DISTAL TUBULES AND COLLECTING DUCTS to prevent Na/K exchange 2)this causes Na/Cl/water loss and K+ retention |
|
Type2 K+ sparing diuretics ADR's (2)
|
1)hyperkalemia is most serious
2)nausea/dizzy |
|
Type2 K+ sparing diuretics uses (2)
|
1)edema of HTN (use w/ thiazides)
2)use w/ other diuretics (thiazides) to augment Na excretion and to reduce K+ loss |
|
Diuretics T/F
a)Water is an osmotic diuretic b)Osmotic diuretics cause acute rapid expansion of ECF c)Loop diuretics usually produce metabolic acidosis and alkaline urine d)Thiazide diuretics act primarily on the ascending arm of the loop of Henle |
a)False
b)True c)False (CAI's do) d)False (distal tubule) |
|
Diuretics T/F
a)Chronic use of thiazide diuretics may cause uric acid retention b)Spironolactone is an aldosterone receptor antagonist c)K+ sparing diuretics are often used in combination w/ carbonic anhydrase inhibitors |
a)True
b)True c)False (thiazides) |
|
Key structural feature of an ACEI
|
must have a proline b/c normal ACE recognize angiotensinI at a proline
|
|
Enalapril is a....
|
ester prodrug that is hydrolyzed to enalaprilat
|
|
ACEI prodrugs (5)
|
1)benzapril
2)enalapril 2)fosinopril 3)quinapril 4)ramipril |
|
Losartan structural features (3)
|
1)imidazole ring
2)tetrazole ring w/ destabilized (-) charge allowing salt formation 3)CH2OH alcohol that is converted to COOH acid (E-3174) which is much more active |
|
Key structural feature of B-blockers
|
aryloxypropanolamine
|
|
What makes a B-blocker cardioselective (B1)?
|
If it has a substituent para to the O2 on the benzene ring
|
|
Osmotic diuretics structural features (2)
|
1)hexol (6-alcohol sugar)
2)not metabolized, so it is excreted unchanged dragging water w/ it when it goes (diuresis) |
|
Carbonic Anhydrase Inhibitors structural features (acetazolamide) (3)
|
1)must inhibit enzyme 99%+ to get any diuresis
2)1,3,4 thiazide derivative 3)has a sulfonamide group that causes diuresis |
|
Loop diuretics structural features (3)
|
1)sulfonamide group
2)e- withdrawing group 3)free COOH = water soluble |
|
Thiazide structural features (3)
|
1)2 fused six member rings
2)1,2,4 thiazide derivatives 3)no carbonic anhydrase activity |
|
Things essential for Thiazide diuretic activity (3) and (1) that decr activity
|
1)sulfonamide @ position 7***
2)electron withdrawing group (Cl, CF3) @ position 6 3)3,4 saturation makes it 10x more active than unsaturated 1)have a H or CH3 or CH3O at position 6 |
|
a)Normal BP
b)Prehypertension c)Stage1 HTN d)Stage2 HTN |
a)<120/80
b)120-139 over 80-89 c)140-159 over 90-99 d)>160/100 Systole goes up by 20 each time, Diastole goes up by 10 each time |
|
HTN begins @...
|
140/90
|
|
When taking BP reading you must base them on...
|
average of 2 or more seated readings taken @ each of 2 or more visits/days
|
|
Rule if systole and diastole are in different categories
|
the HIGHER category should be selected to classify BP status
|
|
Isolated systolic HTN?
|
systole over 140 and diastole less than 90
|
|
Recommended follow up for...
a)Normal BP b)PreHTN c)Stage1 HTN d)Stage2 HTN |
a)recheck in 2 yrs
b)recheck in 1 yr c)confirm within 2 months d)evaluate or refer to source of care within 1 month; if >180/110 treat immediately or within 1wk |
|
Ppl who are normotensive @ age 55 have a ___% chance of...
|
90% lifetime risk of developing HTN
|
|
Relationship b/w BP and CVD risk? (2)
|
incr BP = incr CVD risk and v.v
higher the BP greater the chance of MI, heart failure, CVA and kidney disease |
|
Major risk factor for CVD?
|
systolic BP HTN and is responsible for most uncontrolled HTN
|
|
Controlling systolic BP = (4)
|
1)decr mortality
2)decr CV mortality 3)decr CVA 4)decr heart failure |
|
End organ damage of CVD on the heart (4)
|
1)left ventricular hypertrophy
2)angina/MI 3)prior coronary revascularization 4)heart failure |
|
End organ damage of CVD on the brain (2)
|
1)stroke
2)transient ischemic attack |
|
Other End organ damage of CVD (3)
|
1)chronic kidney disease
2)retinopathy 3)peripheral arterial disease |
|
4 objectives when evaluating a HTN pt
|
1)assess lifestyle and other CV risk factors
2)reveal identifiable causes of high BP (like secondary HTN) 3)assess presence or absence of target organ damage and CVD 4)acquire data thru medical history, physical exam, lab test |
|
Information to be obtained in the medical history while evaluating a pt for HTN (9)
|
1)known duration and levels of BP
2)pt history/symptoms of CHD, CVD, heart failure, etc... 3)family history of high BP, premature CHD 4)symptoms suggesting secondary causes of HTN 5)history of physical activity, smoking/tobacco 6)dietary assessment including intake of Na, EtOH, saturated fat, caffeine 7)history of meds (Rx, OTC, herbal, ilicit) 8)results and ADR's of previous antiHTN therapy 9)mental/environmental factors that may influence HTN control |
|
Lab/diagnostic tests to be done on HTN pts (3)
|
1)urinalysis
2)blood chemistry 3)EKG |
|
Purpose of urinalysis in HTN analysis
|
assess for target organ damage
|
|
Purpose of EKG in HTN analysis (2)
|
1)assess for CVD
2)establish baseline prior to selecting drug |
|
Blood chemistry in HTN analysis tests for...(6)
|
1)K
2)Na 3)Cr 4)fasting glucose 5)fasting lipid profile 6)BASELINE levels for all these things |
|
BB may be CI in pts w/...
|
baseline bradycardia (DEFINED AS HEART RATE LOWER THAN 60 BPM)
|
|
Goals of prevention and treatment of HTN (3)
|
1)reduce CV and renal morbidity and mortality
2)achieve SBP goal (most will reach DBP goal once they have reached SBP goal) 3)control other CV risk factors (ie smoking, lipids) |
|
130/80 is the BP goal of... (3)
|
1)DM
2)renal disease 3)CAD or high CAD risk |
|
140/90 is the BP goal of...
|
1)uncomplicated HTN
|
|
120/80 is the BP goal of... (2)
|
1)heart failure
2)LVD |
|
CAD or high CAD risk consists of... (9)
|
1)angina
2)MI (STEMI/NSTEMI) 3)carotid artery disease 4)peripheral arterial disease 5)abdominal aortic aneurysm 6)DM 7)chronic kidney disease 8)Framingham risk score >10% 9)operations like CABG, stint, PCI/angioplasty |
|
Lifestyle modifications for HTN prevention and management (6)
|
1)weight reduction
2)adopt DASH (dietary approaches to stop HTN) eating plan 3)dietary Na reduction 4)physical activity 5)moderation of EtOH consumption 6)stop smoking |
|
Goals of...for HTN management
a)weight b)DASH diet c)dietary Na reduction |
a)BMI less than 25
b)high in fruits and veggies, low in salt and total fats c)less than 2.4g Na or 6g NaCl |
|
Goals of...for HTN management
a)physical activity b)moderation of EtOH consumption |
a)30mintues of aerobic activity 5+ days of the week (emphasize easing into it)
b)2 drinks for men, 1 for women (1 drink = 12oz beer, 5oz wine, 1.5oz whiskey) |
|
Classes of drugs to use first for HTN and which really first? and which LAST? (5)
|
1)THIAZIDE***
2)ACEI 3)ARB 4)CCB 5)BB |
|
Current principles of Drug addition and titration for HTN (7)
|
1)start w/ lowest dose possible
2)use once daily agents if possible to incr compliance 3)USE THIAZIDES FIRST FOR UNCOMPLICATED HTN 4)for compelling indications first HTN drug does NOT have to be thiazide, but if BP is not controlled by the first drug THIAZIDE is the next one added, ALWAYS 5)2nd drug of different class should be initiated if first drug alone fails after a month 6)if BP is 20/10 above goal, start w/ two drugs initially 7)if treatment fails consider possible reasons why before adding new agent (noncompliance most common) |
|
Follow up and monitoring of HTN once drug therapy is initiated (3)
|
1)follow up @ monthly intervals until BP goal is achieved
2)serum K+ and SCr monitored 1-2x per year 3)once BP is @ goal and stable, follow up can be extended to 3-6month interval |
|
Common ADR's of thiazides and loop diuretics (4)
|
1)short term incr in cholesterol and glc
2)decr K, Na, Cl, Mg 3)incr Cr, uric acid, Ca 4)incr urination freq |
|
Thiazides
a)dosing range b)dosing freq c)monitor what? (3) d)not good for who? |
a)12.5-50mg (25 max for HTN)
b)qd in AM c)K, SCr, BP for efficacy d)not good for ppl w/ GFR below 30 |
|
Loop diuretic
a)dosing range b)dosing freq c)monitor what? (3) d)use |
a)40-240mg
b)bid-tid c)K, SCr, BP for efficacy d)mostly for edema but can be used for HTN if pt has renal disease |
|
K+ sparing diuretic
a)dosing range b)dosing freq c)monitor what? (3) |
a)25-100mg
b)qd c)K can incr, SCr, BP for efficacy |
|
Aldosterone receptor blockers
a)daily dosing range b)dosing freq c)montor what? (4) |
a)25-50mg
b)qd-bid c)K+, SCr, BP, gynecomastia |
|
Renin inhibitor
a)daily dosing range b)dosing freq c)ADR's (4) c)monitor what? (3) |
a)150-300mg
b)qd c)angioedema, hyperkalemia, GI/diarrhea, dizziness d)K, SCr, BP |
|
3 drug classes that CI pregnancy
|
1)aliskiren (renin inhibitor)
2)ARB 3)ACEI |
|
Central alpha-agonist
a)dosing range b)dosing freq c)ADR's d)monitor what? (2) e)1ex |
a)0.2-1.2mg
b)bid-tid c)withdrawal rebound HTN d)BP, EKG e)clonidine |
|
Alpha blocker
a)dosing range b)dosing freq c)ADR's d)monitor what? e)1ex |
a)1-16mg
b)qd c)postural HTN d)BP e)doxazosin |
|
Common ADR's of BB (5)
|
1)BRADYCARDIA (if adding or upping a BB do NOT drop HR below 60)
2)brochospasm in asthmatics/lung diseases 3)heart failure 4)mask hypoglycemia 5)sexual dysfxn |
|
Atenolol
a)dosing range b)dosing freq c)monitor what? (3) d)cardio selectivity decr w/ what? |
a)25-100mg
b)qd c)BP, HR**, EKG d)w/ incr dose |
|
Propranolol
a)dosing range b)dosing freq c)monitor what? (3) |
a)40-480mg
b)bid c)BP, HR**, EKG |
|
Combined alpha-beta blocker
a)dosing range c)dosing freq d)ADR's (1) c)monitor what? (2) e)1ex |
a)12.5-50mg
b)bid c)postural hypotension d)BP, EKG e)coreg |
|
Direct Vasodilators
a)dosing range c)dosing freq d)ADR's (1) c)monitor what? (2) |
a)5-100mg
b)qd c)orthostasis d)BP, physical assessment |
|
Verapamil
a)dosing range c)dosing freq c)monitor what? (3) d)ADR's (3) e)class |
a)90-480mg
b)qd-bid c)bradycardia, worsening of systolic fxn in heart failure, constipation d)BP, HR**, EKG (dont lower HR below 60) e)CCB, non-dihydropyridine |
|
Diltiazem
a)dosing range c)dosing freq d)ADR's (2) c)monitor what? (3) e)class |
a)120-360mg
b)qd-bid c)bradycardia, worsening of systolic fxn d)BP, HR**, EKG e)CCB, non-dihydropyridine |
|
Amlodipine (Norvasc)
a)dosing range c)dosing freq c)monitor what? d)ADR's (3) e)class |
a)2.5-10mg
b)qd c)ankle edema d)BP, physical assessment, NO BRADYCARDIA so can use in heart failure e)CCB, dihydropyridine |
|
Verapamil and diltiazem can't be used in what condition and why?
|
heart failure b/c (-) inotropic
|
|
____ and ____ can be used interchangeably
|
ACEI and ARB
|
|
ACE inhibitors
a)dosing range c)dosing freq c)monitor what? (3) d)ADR's (4) e)CI in... f)suprising thing about it |
a)5-40mg
b)qd c)K, SCr, BP d)COUGH, hyperkalemia, elevated SCr, angioedema e)renal stenosis/pregnancy f)even thou it can elevate SCr it it renally protective |
|
ARB's
a)dosing range c)dosing freq c)monitor what? d)ADR's |
a)80-320mg
b)qd c)K, SCr, BP d)hyperkalemia |